HomeCompareSMDM vs JNJ

SMDM vs JNJ: Dividend Comparison 2026

SMDM yields 1072.39% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SMDM wins by $34747869.85M in total portfolio value
10 years
SMDM
SMDM
● Live price
1072.39%
Share price
$0.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34747869.88M
Annual income
$29,361,828,190,053.53
Full SMDM calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SMDM vs JNJ

📍 SMDM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMDMJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMDM + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMDM pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMDM
Annual income on $10K today (after 15% tax)
$91,152.82/yr
After 10yr DRIP, annual income (after tax)
$24,957,553,961,545.50/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SMDM beats the other by $24,957,553,957,559.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMDM + JNJ for your $10,000?

SMDM: 50%JNJ: 50%
100% JNJ50/50100% SMDM
Portfolio after 10yr
$17373934.95M
Annual income
$14,680,914,097,371.46/yr
Blended yield
84.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SMDM
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMDM buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMDMJNJ
Forward yield1072.39%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$34747869.88M$30.3K
Annual income after 10y$29,361,828,190,053.53$4,689.40
Total dividends collected$34340244.75M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SMDM vs JNJ ($10,000, DRIP)

YearSMDM PortfolioSMDM Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$117,939$107,238.61$10,592$272.30+$107.3KSMDM
2$1,308,210$1,182,016.04$11,289$357.73+$1.30MSMDM
3$13,653,314$12,253,529.08$12,123$472.89+$13.64MSMDM
4$134,128,310$119,519,263.94$13,141$629.86+$134.12MSMDM
5$1,240,845,394$1,097,328,102.61$14,408$846.81+$1240.83MSMDM
6$10,815,164,273$9,487,459,700.68$16,021$1,151.60+$10815.15MSMDM
7$88,854,806,066$77,282,580,293.92$18,122$1,588.22+$88854.79MSMDM
8$688,472,042,411$593,397,399,920.91$20,930$2,228.20+$688472.02MSMDM
9$5,033,683,819,126$4,297,018,733,746.03$24,792$3,191.91+$5033683.79MSMDM
10$34,747,869,876,518$29,361,828,190,053.53$30,274$4,689.40+$34747869.85MSMDM

SMDM vs JNJ: Complete Analysis 2026

SMDMStock

The Singing Machine Company, Inc., together with its subsidiaries, engages in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings in North America, Europe, Asia, and Australia. It offers karaoke products under the flagship brand Singing Machine; licensed karaoke microphone products under the Carpool Karaoke brand; microphone accessories and portable Bluetooth microphones under the Party Machine brand; music entertainment singing machines for children under the brand Singing Machine Kids; and karaoke music subscription services for the iOS and Android platforms, as well as a web-based download store and integrated streaming services for Singing Machine hardware. The company primarily sells its products to retailers, including national chains, warehouse clubs, department stores, lifestyle merchants, specialty stores, and direct mail catalogs and showrooms. It operates in North America, Europe, Asia, and Australia. The Singing Machine Company, Inc. was founded in 1982 and is headquartered in Fort Lauderdale, Florida.

Full SMDM Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SMDM vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMDM vs SCHDSMDM vs JEPISMDM vs OSMDM vs KOSMDM vs MAINSMDM vs ABBVSMDM vs MRKSMDM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.